Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography.
about
Teicoplanin versus vancomycin for proven or suspected infectionDaptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococciTreatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesisBiofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.Efficacy of temafloxacin in experimental Streptococcus adjacens endocarditis and autoradiographic diffusion pattern of [14C]temafloxacin in cardiac vegetations.Optimal aminoglycoside dosing regimen for penicillin-tobramycin synergism in experimental Streptococcus adjacens endocarditis.Thrombin-induced platelet microbicidal protein susceptibility phenotype influences the outcome of oxacillin prophylaxis and therapy of experimental Staphylococcus aureus endocarditis.Development of genetic tools for in vivo virulence analysis of Streptococcus sanguinis.In vivo activities and penetration of the two components of the streptogramin RP 59500 in cardiac vegetations of experimental endocarditis.Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin.Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditis.Acceleration of Enterococcus faecalis biofilm formation by aggregation substance expression in an ex vivo model of cardiac valve colonizationShort-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.Diffusion of ofloxacin in the endocarditis vegetation assessed with synchrotron radiation UV fluorescence microspectroscopy.Activity and diffusion of LY333328 in experimental endocarditis due to vancomycin-resistant Enterococcus faecalis.Consequences of VanE-type resistance on efficacy of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecalisComparison of antimicrobial agents as therapy for experimental endocarditis: caused by methicillin-resistant Staphylococcus aureus.Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the EuInfluence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis.Right-sided endocarditis caused by Staphylococcus aureus in drug abusers.Pharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot model.Differential increased survival of staphylococci and limited ultrastructural changes in the core of infected fibrin clots after daptomycin administration.Pharmacodynamics of once- or twice-daily levofloxacin versus vancomycin, with or without rifampin, against Staphylococcus aureus in an in vitro model with infected platelet-fibrin clots.Population pharmacokinetic study of teicoplanin in severely neutropenic patients.Efficacy of sparfloxacin and autoradiographic diffusion pattern of [14C]Sparfloxacin in experimental Staphylococcus aureus joint prosthesis infection.Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis modelSuccessful single-dose teicoplanin prophylaxis against experimental streptococcal, enterococcal, and staphylococcal aortic valve endocarditis.Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.Infective Endocarditis in Intravenous Drug Abusers.In vivo synergism of ceftobiprole and vancomycin against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus.Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis.Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamase.Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditisSingle-dose antibiotic therapy: what has the past taught us?Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis.Dextranase enhances antibiotic efficacy in experimental viridans streptococcal endocarditis.Beta-lactams versus glycopeptides in treatment of subcutaneous abscesses infected with Staphylococcus aureus.Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremia.Teicoplanin versus vancomycin for prophylaxis of experimental Enterococcus faecalis endocarditis in rats.Efficacy of telavancin in the treatment of experimental endocarditis due to glycopeptide-intermediate Staphylococcus aureus
P2860
Q24234764-6EEA83C0-414D-4FAA-B788-7480D8C1989EQ26851754-691081FE-940B-4F7B-A6D1-FD15DDA035AEQ28368185-7958C087-AD91-4C92-B5C8-D30F560A530DQ30403958-CED78610-6DB3-419B-B13E-169242B13763Q30833424-A0B176A4-0200-43CA-9D0B-B10228BC8D01Q30901078-6EDA5D3D-0164-497D-9051-F72F8D573108Q33595252-F4E1C67F-35CB-467E-B858-62F909A43213Q33697939-DD129073-28FB-4C40-9987-113185D72F9EQ33750394-613D5888-58AE-46C1-AAF0-E04E672BD175Q33750776-1C4A5DB2-4584-4023-85F5-973C903A0FDCQ33758399-D688B659-28B7-47FD-A9ED-2C699FE65DEDQ33786894-3331B8F4-B99F-4F7B-AE9E-509A128435ACQ33883648-C3AE0259-D5CD-4100-8305-00A66CB2E19EQ33894927-BD1A0459-FC2E-4A43-AECC-FCBD9B1E02F6Q33975885-F30DC505-75B1-4019-BD69-1F8F29785799Q33983143-B91FD316-DE76-4683-AA2F-E12E3FD571BEQ34090666-03D2CCB5-AE0F-4442-947D-3C7A1F27E0EAQ34611253-2DE46E58-CD69-4C71-AEE2-4FEDC7D9A01DQ35014464-66C74C50-76DB-43F4-AD71-DBDCC0A840D6Q35111909-9EED854F-5980-4064-9BE7-B8D9E7F31924Q35116133-B832EE2D-CE32-41DC-ABC6-51DA2DD0F29AQ35121985-070752D5-201B-4F92-9445-29C5A6C2AD3FQ35123155-3AB53E22-37F5-436A-A018-C8BE7DE07660Q35124463-BFA2C3AA-7147-4883-8F45-DBE15BBA6C10Q35126785-CC66AC20-FF3C-4AC0-9C51-AFD760E97EBAQ35135145-67609D5B-BF5D-4E12-A75B-B2BFC5A7C11BQ35138023-9D60D7A8-447D-4D12-90BA-E7E7D7DD8B36Q35138989-E570D8D0-BBA4-4ADE-BA5D-2E2A63D420ECQ35179332-5AE6A82F-FC1C-4E6F-A7ED-9977CD532C48Q35191417-52222196-AF14-4C24-BC82-9BCCC713C4DCQ35251599-3D4EA2B2-B6B6-46D4-8826-0ADFD7643187Q35280038-28BEDD54-9133-4355-BA48-3B49D66AEC4FQ35534742-85923BDE-0D5B-48CD-ACCF-36357C6D8477Q35661686-66935A2E-06A5-45D1-A658-397963704552Q35819639-9A3B8C60-AD66-487E-BDE9-3AD036DB5664Q35820158-B3C4FF32-D0E1-4DD7-843D-ED2B0E1D8BBFQ35820407-B4E213F1-F81D-4470-BA11-DF30913B0320Q35836523-183C3C7F-BADA-4976-819C-4FD44149D473Q35862707-4648B94D-9729-4E5D-A1F8-04060D705207Q35879100-BA46EC2D-540D-44F1-8DBB-E7D3A5D1C984
P2860
Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Evaluation of antibiotic diffu ...... quantitative autoradiography.
@en
type
label
Evaluation of antibiotic diffu ...... quantitative autoradiography.
@en
prefLabel
Evaluation of antibiotic diffu ...... quantitative autoradiography.
@en
P2093
P356
P1476
Evaluation of antibiotic diffu ...... quantitative autoradiography.
@en
P2093
Cremieux AC
Ottaviani M
Pocidalo JJ
Vallois JM
P304
P356
10.1093/INFDIS/159.5.938
P407
P577
1989-05-01T00:00:00Z